Is paradoxical pharmacology a strategy worth pursuing?
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 22 (6) , 273-276
- https://doi.org/10.1016/s0165-6147(00)01711-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodiesThe Lancet, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Neurobiological correlates of a putative risk allele for Alzheimer’s disease on chromosome 12qNeurology, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Anti-hyperactivity medication: methylphenidate and amphetamineMolecular Psychiatry, 1998
- Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's diseaseBrain Research, 1998
- Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart diseaseThe Lancet, 1997
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982